Q1 sales = $141K
Q2 sales = $212K
Last estimate from CEO for 2014 to be on the lower end of estimate and Q3 to be on target. So Q3 that is reported in November should be @ $300K and Q4 @ $500K. Sorry for the reality check.
Filed July 28th (PMA). Assume @180 days = End of January / February. More importantly, can they complete this offering this month? if so at what price? The CEO has a tendency of over promising and under delivering. For example, GTHP refiled the PMA over 30 days late after CEO saying on press release and in 2 conferences they will going to refile by the end of June. Great product but a horrible mgmt team. I made the mistake of falling in love with the product but be very very careful because the mgmt team is not able to keep promises or deadlines.
My thoughts exactly.... My last post at investor village sounds similar to yours. I pasted mine below....
I am really puzzled by how much this board loves Mr. Cartwright. I had several conversations with Mr. Cartwright during the last 2 months. He is an extremely nice and open person. However, in my modest opinion, his execution is poor at best. In a matter of fact, it was Mr. Cartwright that told me to expect completion of the offering by the end of the month (October). He communicated the same to others in this board. When I spoke with him October 30th, he said he was hoping for completion of the offering in early November and felt confident of completion by November 14th. However, November 14th the offering was not completed. Instead we got another update. This time we where told at the beginning of the conference call to expect completion within days. As of November 21 (one week later) we are still waiting. Do you see the pattern? Don't you think he has over promised and under delivered again?
More importantly, GTHP stock price has plunged this year. As an investor stock performance is a key driver to determine how effective the mgmt has performed. I will keep quiet about Mr. Cartwright going forward since everyone in this board has a man crush on the guy. Maybe if the stock moves below 20 cents your support for Mr. Cartwright will increase.
Let's hope for completion of the offering next week and that we finally start seeing large orders next month. I keep hoping and WE OBVIOUSLY WANT THE SAME OUTCOME. Best luck to you and truly hope Mr. Cartwright shows everyone in this board how wrong I am about him. That would be a very nice change.
Good clinical studies results from Nigeria and Turkey. I believe the next step to move us higher is insider buying and a large order prior to year end. I would be surprised if insiders did not use the opportunity to buy additional shares at 22.5 cents. The offering was closed yesterday so we should find soon if insiders participated in the offering. In addition, during the last conference call Mr. Cartwright hinted about the possibility of getting Banglasdesh prior to year-end. News of insiders buying and large order could set us up for a nice rally ahead of FDA news (panel review date). An update from FDA is expected @ the end of January.
Personally think that Cartwright needs to be more careful with his "guidance". As a CEO he needs to learn to be more cautious. He is willing to talk to shareholders but tends over promise and under/never deliver. Let's talk less and have at least 1 press releases about large orders and the sentiment will change dramatically. DELIVER RESULTS! Show me. Do not tell me.
Lilith/jennifer/punta/GTPH 10 bagger..... I agree with you on you last comment. I thought a partnership instead of a offering was a better path. My only hope is that insiders are using this offering to accumulate shares before a run up. If they complete the offering will like to know which insiders bought and how much.
Now that the offering is completed and insiders probably loaded at 22.5 cents will we start getting good news flow? Are we finally going to hear from mgmt regarding accelerating sales in 2015? Tide is finally turning it seems. I wish I was starting my position here. Time to average down my cost basis.
I could not agree more. I am betting / hoping we start seeing large orders sooner rather than later. Maybe I am just too jaded but now that the offering is completed I expect news flow to improve dramatically. We are due anyhow :-).... So Bangladesh next week!
As far as I am concerned Cartwright has consistently over promised and under delivered. He needs to keep his mouth shut and start delivering for a change. Just my 2 cents and rant :-). How about firing Faupel and his $200K salary DESPITE his demotion from CEO to "Scientific officer". That is a good start.
At the end of the day we are going to have to wait until the financing is completed. I am not selling my shares, but realize I was too bullish about Luviva without fully considering the balance sheet. I was not expecting for Cartwright & co to fumble so many times with the PMA refiling. I was hoping for refiling in March not July.... I am mentally prepared if the shares go to zero. It is going to hurt but it will not kill me. I have reservations with the capital raise. Maybe they are doing the best they can presently without large orders and without a panel review date. In summary, I am hoping (not a good place to be) for the best but I could not recommend the stock.
I am also extremely discouraged with the mgmt team and Mr. Cartwright. They are killing shareholders. IMHO, the way they are raising capital is very shareholder Unfriendly. Not much I can do other than to dump my shares. I am waiting for FDA.... because I do not have much of a choice at current prices.
Imhoff that sold monthly? What are you talking about? Hart sold some shares. Show me when Imhoff sold shares! The offering will be done. expect @$6mm at 30 cents and expect the stock to rally if it gets done at those levels.
The mgt team is awful but after the completion of the offering hopefully this week @ 30 cents GTHP becomes a pure FDA play. Cartwright does not have the luxury of getting the offering done a month late like the PMA refiling. Oct 31 is a key date (deadline for offering) for this stock. If we can get over this hurdle the stock might lift and rally ahead of FDA decision. Hopefully, we will get a panel review date for early 2015 sooner rather than later. Best of luck.
Jennifer ,I am sorry but you are wrong. Seanoise is one of our best contributors at this message board. His information is precise and correct. Look....I am very critical of the mgmt team. I am telling you that I highly doubt GTHP will not complete the offering. I think the market priced the worse case scenario. They will probably raise about $6mm. If they can accomplish that task at 30 cents the stock will rally. BK will be out of the question and then it becomes purely a FDA play. I think the shares are ralling because details of the offering are getting leaked and now looks like GTHP will have plenty of funds. I think it is that simple. There is little resistance until 40 cents. Beyond 46 cents we need large orders or FDA information to take us higher.
I am very bullish on GTHP right now. I think we are on the brink of significant changes to the capital structure that are long term positive for GTHP. In essence, the offering will delete the BK option and enables us to wait for the FDA. Obviously I am expecting FDA approval in early 2015 for Luviva. However, I was hoping for the offering to be done by now. Based on the timing of the PR I am guessing outstanding issues are getting resolved and Nov 14th seems a logical time to complete the offering. My hope is at least $6mm @ 30 cents.